158 related articles for article (PubMed ID: 8817189)
1. Pseudomonas aeruginosa clinical isolates: serotypes, resistance phenotypes and plasmid profiles.
Millesimo M; de Intinis G; Chirillo MG; Musso T; Savoia D
Eur J Epidemiol; 1996 Apr; 12(2):123-9. PubMed ID: 8817189
[TBL] [Abstract][Full Text] [Related]
2. Plasmid profiles compared with serotyping and pyocin typing for epidemiological surveillance of Pseudomonas aeruginosa.
Poh CL; Yap EH; Tay L; Bergan T
J Med Microbiol; 1988 Feb; 25(2):109-14. PubMed ID: 3123694
[TBL] [Abstract][Full Text] [Related]
3. Phenotypic and genotypic characterization of Pseudomonas aeruginosa from cystic fibrosis patients.
Leone I; Chirillo MG; Raso T; Zucca M; Savoia D
Eur J Clin Microbiol Infect Dis; 2008 Nov; 27(11):1093-9. PubMed ID: 18488256
[TBL] [Abstract][Full Text] [Related]
4. Concept of segmentation in nosocomial epidemiology: epidemiological relation among antimicrobial-resistant isolates of Pseudomonas aeruginosa.
Kinoshita M; Sawabe E; Okamura N
J Infect; 1997 Nov; 35(3):269-76. PubMed ID: 9459401
[TBL] [Abstract][Full Text] [Related]
5. Prevalence and profiles of plasmids in Pseudomonas aeruginosa.
Plesiat P; Alkhalaf B; Michel-Briand Y
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):261-4. PubMed ID: 3134228
[TBL] [Abstract][Full Text] [Related]
6. Mixed morphotype susceptibility testing of Pseudomonas aeruginosa from patients with cystic fibrosis.
Dunne WM; Chusid MJ
Diagn Microbiol Infect Dis; 1987 Feb; 6(2):165-70. PubMed ID: 3102157
[TBL] [Abstract][Full Text] [Related]
7. Protein patterns, serotyping and plasmid DNA profiles in the epidemiologic fingerprinting of Pseudomonas aeruginosa.
Walia S; Madhavan T; Williamson T; Kaiser A; Tewari R
Eur J Clin Microbiol Infect Dis; 1988 Apr; 7(2):248-55. PubMed ID: 3134227
[TBL] [Abstract][Full Text] [Related]
8. Characterization of Pseudomonas aeruginosa strains isolated from cystic fibrosis patients by different typing methods.
Hafiane A; Ravaoarinoro M
Pathol Biol (Paris); 2011 Oct; 59(5):e109-14. PubMed ID: 19896303
[TBL] [Abstract][Full Text] [Related]
9. Molecular epidemiological analysis of Pseudomonas aeruginosa strains causing failure of antibiotic therapy in cystic fibrosis patients.
Bingen E; Denamur E; Picard B; Goullet P; Lambert-Zechovsky N; Foucaud P; Navarro J; Elion J
Eur J Clin Microbiol Infect Dis; 1992 May; 11(5):432-7. PubMed ID: 1358612
[TBL] [Abstract][Full Text] [Related]
10. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
[TBL] [Abstract][Full Text] [Related]
11. Diversity of resistance phenotypes and plasmid analysis in multi-resistant 0:12 Pseudomonas aeruginosa.
Tsakris A; Vatopoulos AC; Tzouvelekis LS; Legakis NJ
Eur J Epidemiol; 1992 Nov; 8(6):865-70. PubMed ID: 1294394
[TBL] [Abstract][Full Text] [Related]
12. Bacteriophages in sputum of cystic fibrosis patients as a possible cause of in vivo changes in serotypes of Pseudomonas aeruginosa.
Ojeniyi B
APMIS; 1988 Apr; 96(4):294-8. PubMed ID: 3130885
[TBL] [Abstract][Full Text] [Related]
13. Within-host microevolution of Pseudomonas aeruginosa in Italian cystic fibrosis patients.
Marvig RL; Dolce D; Sommer LM; Petersen B; Ciofu O; Campana S; Molin S; Taccetti G; Johansen HK
BMC Microbiol; 2015 Oct; 15():218. PubMed ID: 26482905
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa diversity in distinct paediatric patient groups.
Tramper-Stranders GA; van der Ent CK; Wolfs TF; Kimpen JL; Fleer A; Johansen U; Johansen HK; Høiby N
Clin Microbiol Infect; 2008 Oct; 14(10):935-41. PubMed ID: 18752596
[TBL] [Abstract][Full Text] [Related]
15. Antibiotic susceptibility and serotyping of Pseudomonas aeruginosa strains isolated from surface waters, thermomineral waters and clinical specimens.
Reali D; Rosati S
Zentralbl Hyg Umweltmed; 1994 Aug; 196(1):75-80. PubMed ID: 7802899
[TBL] [Abstract][Full Text] [Related]
16. Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
Burns JL; Gibson RL; McNamara S; Yim D; Emerson J; Rosenfeld M; Hiatt P; McCoy K; Castile R; Smith AL; Ramsey BW
J Infect Dis; 2001 Feb; 183(3):444-52. PubMed ID: 11133376
[TBL] [Abstract][Full Text] [Related]
17. [Investigation of biofilm formation and relationship with genotype and antibiotic susceptibility of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis].
Coban AY; Ciftci A; Onuk EE; Erturan Z; Tanriverdi Cayci Y; Durupinar B
Mikrobiyol Bul; 2009 Oct; 43(4):563-73. PubMed ID: 20084909
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic resistance and population structure of cystic fibrosis Pseudomonas aeruginosa isolates from a Spanish multi-centre study.
López-Causapé C; de Dios-Caballero J; Cobo M; Escribano A; Asensio Ó; Oliver A; Del Campo R; Cantón R; Solé A; Cortell I; Asensio O; García G; Martínez MT; Cols M; Salcedo A; Vázquez C; Baranda F; Girón R; Quintana E; Delgado I; de Miguel MÁ; García M; Oliva C; Prados MC; Barrio MI; Pastor MD; Olveira C; de Gracia J; Álvarez A; Escribano A; Castillo S; Figuerola J; Togores B; Oliver A; López C; de Dios Caballero J; Tato M; Máiz L; Suárez L; Cantón R
Int J Antimicrob Agents; 2017 Sep; 50(3):334-341. PubMed ID: 28735882
[TBL] [Abstract][Full Text] [Related]
19. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
[TBL] [Abstract][Full Text] [Related]
20. Comparison of genome fingerprinting with conventional typing methods used on Pseudomonas aeruginosa isolates from cystic fibrosis patients.
Ojeniyi B; Petersen US; Høiby N
APMIS; 1993 Feb; 101(2):168-75. PubMed ID: 8098219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
